Similar articles

• [Surfactant treatment of premature infants with respiratory distress syndrome].

  Saugstad OD, Gloppestad K. Saugstad OD, et al. Tidsskr Nor Laegeforen. 1990 Nov 30;110(29):3737-41. Tidsskr Nor Laegeforen. 1990. PMID: 2274941 Clinical Trial. Norwegian.
• [Surfactant therapy of premature infants. Complications and mortality are reduced].

  Hjalmarson O. Hjalmarson O. Lakartidningen. 1993 Nov 10;90(45):3938-40. Lakartidningen. 1993. PMID: 8231562 Swedish. No abstract available.
• The 5 W's of surfactant for respiratory distress syndrome of the premature infant.

  Parmigiani S. Parmigiani S. J Matern Fetal Neonatal Med. 2004 Nov;16 Suppl 2:25-7. doi: 10.1080/14767050410001727143. J Matern Fetal Neonatal Med. 2004. PMID: 15590430 Review.
• Surfactant-replacement therapy for respiratory distress in the preterm and term neonate.

  Engle WA; American Academy of Pediatrics Committee on Fetus and Newborn. Engle WA, et al. Pediatrics. 2008 Feb;121(2):419-32. doi: 10.1542/peds.2007-3283. Pediatrics. 2008. PMID: 18245434
• Respiratory distress syndrome and intracranial hemorrhage: cause or association? Inferences from surfactant clinical trials.

  Leviton A, VanMarter L, Kuban KC. Leviton A, et al. Pediatrics. 1989 Nov;84(5):915-22. Pediatrics. 1989. PMID: 2677963 Review. No abstract available.